These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 24700776)
41. Nerve guidance channels as drug delivery vehicles. Piotrowicz A; Shoichet MS Biomaterials; 2006 Mar; 27(9):2018-27. PubMed ID: 16239029 [TBL] [Abstract][Full Text] [Related]
42. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568 [TBL] [Abstract][Full Text] [Related]
43. Mapping microclimate pH distribution inside protein-encapsulated PLGA microspheres using confocal laser scanning microscopy. Liu Y; Schwendeman SP Mol Pharm; 2012 May; 9(5):1342-50. PubMed ID: 22428586 [TBL] [Abstract][Full Text] [Related]
44. Effect of stabilizers on bioactivity of peptide-24 in PLGA microspheres. Wang M; Guo X; Tan R; She Z; Feng Q Med Chem; 2013 Dec; 9(8):1123-8. PubMed ID: 23227911 [TBL] [Abstract][Full Text] [Related]
45. Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI). Cocks E; Somavarapu S; Alpar O; Greenleaf D Pharm Res; 2014 Aug; 31(8):2000-9. PubMed ID: 24549823 [TBL] [Abstract][Full Text] [Related]
46. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893 [TBL] [Abstract][Full Text] [Related]
47. RhBMP-2-loaded Poly(lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for protein delivery. Zhang M; Ma Y; Li R; Zeng J; Li Z; Tang Y; Sun D J Biomater Sci Polym Ed; 2017 Dec; 28(18):2205-2219. PubMed ID: 28988518 [TBL] [Abstract][Full Text] [Related]
48. PLGA/alginate composite microspheres for hydrophilic protein delivery. Zhai P; Chen XB; Schreyer DJ Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():251-9. PubMed ID: 26249587 [TBL] [Abstract][Full Text] [Related]
49. Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration. Nath SD; Son S; Sadiasa A; Min YK; Lee BT Int J Pharm; 2013 Feb; 443(1-2):87-94. PubMed ID: 23291448 [TBL] [Abstract][Full Text] [Related]
50. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
51. Silk coatings on PLGA and alginate microspheres for protein delivery. Wang X; Wenk E; Hu X; Castro GR; Meinel L; Wang X; Li C; Merkle H; Kaplan DL Biomaterials; 2007 Oct; 28(28):4161-9. PubMed ID: 17583788 [TBL] [Abstract][Full Text] [Related]
52. PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins. Minardi S; Pandolfi L; Taraballi F; De Rosa E; Yazdi IK; Liu X; Ferrari M; Tasciotti E ACS Appl Mater Interfaces; 2015 Aug; 7(30):16364-73. PubMed ID: 26108253 [TBL] [Abstract][Full Text] [Related]
53. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581 [TBL] [Abstract][Full Text] [Related]
54. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. Carrasquillo KG; Stanley AM; Aponte-Carro JC; De Jésus P; Costantino HR; Bosques CJ; Griebenow K J Control Release; 2001 Oct; 76(3):199-208. PubMed ID: 11578736 [TBL] [Abstract][Full Text] [Related]
55. Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: thioester formation as a reason for incomplete release. Ghalanbor Z; Körber M; Bodmeier R Int J Pharm; 2012 Nov; 438(1-2):302-6. PubMed ID: 22989984 [TBL] [Abstract][Full Text] [Related]
56. Mathematical modelling of the evolution of protein distribution within single PLGA microspheres: prediction of local concentration profiles and release kinetics. Mollica F; Biondi M; Muzzi S; Ungaro F; Quaglia F; La Rotonda MI; Netti PA J Mater Sci Mater Med; 2008 Apr; 19(4):1587-93. PubMed ID: 17992472 [TBL] [Abstract][Full Text] [Related]
57. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. Ho ML; Fu YC; Wang GJ; Chen HT; Chang JK; Tsai TH; Wang CK J Control Release; 2008 Jun; 128(2):142-8. PubMed ID: 18436324 [TBL] [Abstract][Full Text] [Related]
58. Chemical and spatial analysis of protein loaded PLGA microspheres for drug delivery applications. Rafati A; Boussahel A; Shakesheff KM; Shard AG; Roberts CJ; Chen X; Scurr DJ; Rigby-Singleton S; Whiteside P; Alexander MR; Davies MC J Control Release; 2012 Sep; 162(2):321-9. PubMed ID: 22580112 [TBL] [Abstract][Full Text] [Related]
59. Release of bovine serum albumin from preformed porous microspheres of poly(L-lactic acid). Puri N; Jones AB; Kou JH; Wyandt CM J Microencapsul; 2000; 17(2):207-14. PubMed ID: 10738696 [TBL] [Abstract][Full Text] [Related]
60. New insights into the pore structure of poly(d,l-lactide-co-glycolide) microspheres. Vay K; Scheler S; Friess W Int J Pharm; 2010 Dec; 402(1-2):20-6. PubMed ID: 20883760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]